BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16153852)

  • 1. Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents.
    Zhu S; Ruchelman AL; Zhou N; Liu AA; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2005 Dec; 13(24):6782-94. PubMed ID: 16153852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.
    Ruchelman AL; Zhu S; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5585-9. PubMed ID: 15482929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Substituted 6H-dibenzo[c,h][2,6]naphthyridin-5-ones: reversed lactam analogues of ARC-111 with potent topoisomerase I-targeting activity and cytotoxicity.
    Zhu S; Ruchelman AL; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2006 May; 14(9):3131-43. PubMed ID: 16412652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted dibenzo[c,h]cinnolines: topoisomerase I-targeting anticancer agents.
    Yu Y; Singh SK; Liu A; Li TK; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2003 Apr; 11(7):1475-91. PubMed ID: 12628673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents.
    Makhey D; Li D; Zhao B; Sim SP; Li TK; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2003 Apr; 11(8):1809-20. PubMed ID: 12659767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.
    Feng W; Satyanarayana M; Tsai YC; Liu AA; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2008 Sep; 16(18):8598-606. PubMed ID: 18771930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity.
    Ruchelman AL; Singh SK; Ray A; Wu X; Yang JM; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2004 Feb; 12(4):795-806. PubMed ID: 14759740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitro and amino substitution within the A-ring of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: influence on topoisomerase I-targeting activity and cytotoxicity.
    Ruchelman AL; Kerrigan JE; Li TK; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2004 Jul; 12(13):3731-42. PubMed ID: 15186859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3-Dimethoxybenzo[i]phenanthridines: topoisomerase I-targeting anticancer agents.
    Li D; Zhao B; Sim SP; Li TK; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2003 Feb; 11(4):521-8. PubMed ID: 12538017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents.
    Feng W; Satyanarayana M; Cheng L; Liu A; Tsai YC; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2008 Oct; 16(20):9295-301. PubMed ID: 18829334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I.
    Guo W; Miao Z; Sheng C; Yao J; Feng H; Zhang W; Zhu L; Liu W; Cheng P; Zhang J; Che X; Wang W; Luo C; Xu Y
    Eur J Med Chem; 2010 Jun; 45(6):2223-8. PubMed ID: 20202723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug.
    Li TK; Houghton PJ; Desai SD; Daroui P; Liu AA; Hars ES; Ruchelman AL; LaVoie EJ; Liu LF
    Cancer Res; 2003 Dec; 63(23):8400-7. PubMed ID: 14679002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-one (ARC-31).
    Satyanarayana M; Feng W; Cheng L; Liu AA; Tsai YC; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2008 Aug; 16(16):7824-31. PubMed ID: 18676151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents.
    Feng W; Satyanarayana M; Tsai YC; Liu AA; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2009 Apr; 17(7):2877-85. PubMed ID: 19303306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
    Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
    Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.
    Ruchelman AL; Houghton PJ; Zhou N; Liu A; Liu LF; LaVoie EJ
    J Med Chem; 2005 Feb; 48(3):792-804. PubMed ID: 15689163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity and TOP1-targeting activity of 8- and 9-amino derivatives of 5-butyl- and 5-(2-N,N-dimethylamino)ethyl-5H-dibenzo[c,h][1,6]naphthyridin-6-ones.
    Sharma L; Tsai YC; Liu AA; Liu LF; LaVoie EJ
    Eur J Med Chem; 2009 Apr; 44(4):1471-6. PubMed ID: 19012996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR modeling on benzo[c]phenanthridine analogues as topoisomerase I inhibitors and anti-cancer agents.
    Thai KM; Bui QH; Tran TD; Huynh TN
    Molecules; 2012 May; 17(5):5690-712. PubMed ID: 22580401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5H-Dibenzo[c,h]1,6-naphthyridin-6-ones: novel topoisomerase I-targeting anticancer agents with potent cytotoxic activity.
    Ruchelman AL; Singh SK; Ray A; Wu XH; Yang JM; Li TK; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2003 May; 11(9):2061-73. PubMed ID: 12670657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I.
    Streltsov SA
    J Biomol Struct Dyn; 2002 Dec; 20(3):447-54. PubMed ID: 12437383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.